This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lexicon Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Martial Etienne: Innovator in Pharmaceutical Processes
Introduction
Martial Etienne is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of specific crystalline forms of compounds. His work is characterized by innovative processes that enhance the efficiency and effectiveness of drug manufacturing.
Latest Patents
Martial Etienne holds a patent for a "Continuous process for preparing the crystalline form II of sotagliflozin." This patent outlines a method for producing the crystalline form II of sotagliflozin through a continuous process. The process involves several key steps, including the reaction of a specific compound in a solution, followed by crystallization in a non-aqueous solvent medium. This innovative approach not only streamlines the production process but also ensures the purity and quality of the final product.
Career Highlights
Martial Etienne is currently associated with Lexicon Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical processes. His work has been instrumental in advancing the company's research and development efforts. With a focus on continuous improvement and innovation, he has contributed to the development of new methodologies that enhance drug formulation.
Collaborations
Martial has collaborated with several professionals in his field, including Bruno Burel and Jérome Cezerac. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new pharmaceutical processes.
Conclusion
Martial Etienne's contributions to the pharmaceutical industry exemplify the importance of innovation in drug development. His patent for the continuous preparation of sotagliflozin showcases his commitment to improving pharmaceutical processes. Through his work at Lexicon Pharmaceuticals, he continues to make strides in the field, paving the way for future advancements.